NEOS Insider Trading Activity and SEC Form 4 Filings
NEOS insider trading summary
No open-market insider purchases or sales of Neos Therapeutics, Inc. (NEOS) have been reported on SEC Form 4 in the past 12 months.
Latest NEOS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2018 | Richard I Eisenstadt | Chief Financial Officer | Buy | $11K (5,000 @ $2.16) |
| Dec 6, 2018 | Gerald W. McLaughlin | Chief Executive Officer | Buy | $36K (17,097 @ $2.11) |
| Dec 4, 2018 | Gerald W. McLaughlin | Chief Executive Officer | Buy | $15K (7,403 @ $2.04) |
| Nov 8, 2018 | Alan L Heller | Director | Buy | $100K (43,478 @ $2.30) |
| Aug 31, 2016 | Bryant Fong | Director | Buy | $10K (1,500 @ $6.54) |
| Aug 25, 2016 | Richard I Eisenstadt | Chief Financial Officer | Buy | $25K (3,710 @ $6.82) |
| Jun 13, 2016 | Juergen Martens | Chief Tech/Operations Officer | Buy | $99K (10,000 @ $9.90) |
| May 19, 2016 | Alan L Heller | Director | Buy | $76K (10,000 @ $7.61) |
| May 19, 2016 | Thomas P McDonnell | Chief Commercial Officer | Buy | $23K (3,000 @ $7.56) |
| May 18, 2016 | Gregory J Robitaille | Director | Buy | $56K (7,442 @ $7.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.